Inventor · disambiguated record
William Ronald Solvibile
Also filed as: SOLVIBILE JR WILLIAM RONALD · SOLVIBILE WILLIAM · SOLVIBILE WILLIAM R · SOLVIBILE WILLIAM RONALD
16 granted patents·6 pending applications·117 citations·filing 2001–2021
92Inventor score
Top patents by PatentIndex Score
22 records- 0191US7417047B2Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulationWYETH CORP·Filed 2006·Granted Aug 26, 2008·19 cites·12 claims
- 0290US9592221B2Antibacterial agents: aryl myxopyronin derivativesUNIV RUTGERS·Filed 2016·Granted Mar 14, 2017·7 cites·19 claims
- 0389US9315495B2Antibacterial agents: aryl myxopyronin derivativesUNIV RUTGERS·Filed 2013·Granted Apr 19, 2016·8 cites·10 claims
- 0489US7732457B2Amino-pyridines as inhibitors of β-secretaseWYETH LLC·Filed 2006·Granted Jun 8, 2010·15 cites·9 claims
- 0587US6506901B2Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Jan 14, 2003·22 cites·5 claims
- 0686US7459567B2Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulatorsWYETH CORP·Filed 2006·Granted Dec 2, 2008·5 cites·12 claims
- 0784US6537994B2Heterocyclic β3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Mar 25, 2003·16 cites·10 claims
- 0883US6451814B1Heterocyclic β-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Sep 17, 2002·19 cites·8 claims
- 0972US7723368B2Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretaseWYETH LLC·Filed 2008·Granted May 25, 2010·1 cites·27 claims
- 1071US7935719B2N-substituted-azacyclylamines as histamine-3 antagonistsWYETH LLC·Filed 2007·Granted May 3, 2011·1 cites·14 claims
- 1171US7820825B2N-substituted-azacyclylamines as histamine-3 antagonistsWYETH LLC·Filed 2007·Granted Oct 26, 2010·1 cites·11 claims
- 1267US7241791B2Substituted 4-(indazol-3-yl)phenolsWYETH CORP·Filed 2003·Granted Jul 10, 2007·3 cites·8 claims
- 1365US11161864B2Sting agonistsVENENUM BIODESIGN LLC·Filed 2019·Granted Nov 2, 2021·0 cites·18 claims
- 1462US7705030B2Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulationWYETH LLC·Filed 2008·Granted Apr 27, 2010·0 cites·18 claims
- 1561US2022048936A1Novel sting agonistsVENENUM BIODESIGN LLC·Filed 2021·Application pending·0 cites
- 1653US2007225349A1Substituted 4-(Indazol-3-yl)phenolsWYETH CORP·Filed 2007·Application pending·0 cites
- 1748US6605618B2Heterocyclic beta-3 adrenergic receptor agonistsWYETH CORP·Filed 2002·Granted Aug 12, 2003·0 cites·1 claims
- 1848US2010168106A1Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase ModulationWYETH LLC·Filed 2010·Application pending·0 cites
- 1948US2009042964A1Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as beta-secretase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 2043US2010204245A1Amino-pyridines As Inhibitors Of Beta-secretaseWYETH LLC·Filed 2010·Application pending·0 cites
- 2142US2010168194A1Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretaseWYETH LLC·Filed 2010·Application pending·0 cites
- 2240US7378427B2Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridinesWYETH CORP·Filed 2005·Granted May 27, 2008·0 cites·48 claims
Join the waitlist — get patent alerts
Get an alert when William Ronald Solvibile files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →